ACRP CP FINAL EXAM QUESTIONS WITH COMPLETE
SOLUTIONS GUARANTEED PASS BRAND NEW 2025
What is an ADR? -ANSWER ->Adverse drug reaction (ADR)
1.Pre-approval clinical experience with a new medicinal product or its
new usages: all noxious and unintended responses to a medicinal
product related to any dose should be considered adverse drug
reactions. The phrase responses to a medicinal product means that a
causal relationship between a medicinal product and an adverse event
is at least a reasonable possibility, i.e., the relationship cannot be ruled
out.
2. Regarding marketed medicinal products: a response to a drug which
is noxious and unintended and which occurs at doses normally used in
man for prophylaxis, diagnosis, or therapy of diseases or for
modification of physiological function.
What is an AE? -ANSWER ->Adverse event (AE)
1. Any untoward medical occurrence in a patient or clinical
investigation subject administered a pharmaceutical product and which
does not necessarily have a causal relationship with this treatment. An
adverse event (AE) can therefore be any unfavourable and unintended
sign (including an abnormal laboratory finding), symptom, or disease
temporally associated with the use of a medicinal (investigational)
product, whether or not related to the medicinal (investigational)
product.
What is an SAE? -ANSWER ->Serious adverse event (SAE)
1. Results in death
, 2. Is life-threatening
3. Requires inpatient hospitalization or prolongation of existing
hospitalization
4. Results in persistent or significant disability/incapacity
5. Is a congenital anomaly/birth defect
What is an UADR? -ANSWER ->Unexpected adverse drug reaction
(UADR)
1. An adverse reaction, the nature or severity of which is not consistent
with the applicable product information (e.g., IB for an unapproved IP
or package insert/summary of product characteristics for an approved
product)
Who constitutes a vulnerable subject? -ANSWER ->Individuals whose
willingness to volunteer in a clinical trial may be unduly influenced by
the expectation of benefits associated with participation, or of a
retaliatory response from senior members of a hierarchy in case of
refusal to participate.
Examples are members of a group with a hierarchical structure, such as
medical, pharmacy, dental, and nursing students, subordinate hospital
and laboratory personnel, employees of the pharmaceutical industry,
members of the armed forces, and persons kept in detention.
Other vulnerable subjects include patients with incurable diseases,
persons in nursing homes, unemployed or impoverished persons,
patients in emergency situations, ethnic minority groups, homeless
persons, nomads, refugees, minors, and those incapable of giving
consent.
GCP: Clinical trials should be conducted in accordance with the ethical
principles that have their origin in the ___________ __ ________, and
SOLUTIONS GUARANTEED PASS BRAND NEW 2025
What is an ADR? -ANSWER ->Adverse drug reaction (ADR)
1.Pre-approval clinical experience with a new medicinal product or its
new usages: all noxious and unintended responses to a medicinal
product related to any dose should be considered adverse drug
reactions. The phrase responses to a medicinal product means that a
causal relationship between a medicinal product and an adverse event
is at least a reasonable possibility, i.e., the relationship cannot be ruled
out.
2. Regarding marketed medicinal products: a response to a drug which
is noxious and unintended and which occurs at doses normally used in
man for prophylaxis, diagnosis, or therapy of diseases or for
modification of physiological function.
What is an AE? -ANSWER ->Adverse event (AE)
1. Any untoward medical occurrence in a patient or clinical
investigation subject administered a pharmaceutical product and which
does not necessarily have a causal relationship with this treatment. An
adverse event (AE) can therefore be any unfavourable and unintended
sign (including an abnormal laboratory finding), symptom, or disease
temporally associated with the use of a medicinal (investigational)
product, whether or not related to the medicinal (investigational)
product.
What is an SAE? -ANSWER ->Serious adverse event (SAE)
1. Results in death
, 2. Is life-threatening
3. Requires inpatient hospitalization or prolongation of existing
hospitalization
4. Results in persistent or significant disability/incapacity
5. Is a congenital anomaly/birth defect
What is an UADR? -ANSWER ->Unexpected adverse drug reaction
(UADR)
1. An adverse reaction, the nature or severity of which is not consistent
with the applicable product information (e.g., IB for an unapproved IP
or package insert/summary of product characteristics for an approved
product)
Who constitutes a vulnerable subject? -ANSWER ->Individuals whose
willingness to volunteer in a clinical trial may be unduly influenced by
the expectation of benefits associated with participation, or of a
retaliatory response from senior members of a hierarchy in case of
refusal to participate.
Examples are members of a group with a hierarchical structure, such as
medical, pharmacy, dental, and nursing students, subordinate hospital
and laboratory personnel, employees of the pharmaceutical industry,
members of the armed forces, and persons kept in detention.
Other vulnerable subjects include patients with incurable diseases,
persons in nursing homes, unemployed or impoverished persons,
patients in emergency situations, ethnic minority groups, homeless
persons, nomads, refugees, minors, and those incapable of giving
consent.
GCP: Clinical trials should be conducted in accordance with the ethical
principles that have their origin in the ___________ __ ________, and
